Maria Dolores
Chirlaque Lopez
Asociado a Tiempo Parcial
![Foto de Maria Dolores](/img/uploaded/b556d6d2a9b2447a5d110cb58611f508.jpeg)
![Foto de National Institute for Health Development](/img/noimage_org.png)
National Institute for Health Development
Tallin, EstoniaPublicaciones en colaboración con investigadores/as de National Institute for Health Development (19)
2024
-
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307
-
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
The Lancet Oncology, Vol. 25, Núm. 6, pp. 731-743
2023
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
2022
-
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries
The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431
2021
-
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
The Lancet Oncology, Vol. 22, Núm. 7, pp. 1002-1013
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
2020
-
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)
Oral Oncology, Vol. 108
-
Repositioning of the global epicentre of non-optimal cholesterol
Nature, Vol. 582, Núm. 7810, pp. 73-77
2019
2017
-
Geographical variability in survival of European children with central nervous system tumours
European Journal of Cancer, Vol. 82, pp. 137-148
-
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642
2015
-
Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129
-
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143
-
Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2206-2216
-
Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2179-2190
-
Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2191-2205
-
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2104-2119
-
Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2217-2230
2014
-
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study
The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34